Revium Rx
RVRC
$0.52
$0.024.00%
OTC PK
| 09/30/2010 | 06/30/2010 | 03/31/2010 | 09/30/2009 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | 4,955.56% | 24.12% | -96.69% | -97.33% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 4,955.56% | -16.77% | -99.33% | -99.58% | |
| Operating Income | -4,955.56% | -55.63% | 90.78% | -205.88% | |
| Income Before Tax | -4,955.56% | -55.63% | 90.78% | -205.88% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -4,955.56% | -55.63% | 90.78% | -205.88% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -4,955.56% | -55.63% | 90.78% | -205.88% | |
| EBIT | -4,955.56% | -55.63% | 90.78% | -205.88% | |
| EBITDA | -- | -- | -- | -- | |
| EPS Basic | -3,384.86% | -9.01% | 90.89% | -326.13% | |
| Normalized Basic EPS | -3,381.95% | -8.99% | 90.89% | -326.44% | |
| EPS Diluted | -3,384.86% | -9.01% | 90.89% | -326.13% | |
| Normalized Diluted EPS | -3,381.95% | -8.99% | 90.89% | -326.44% | |
| Average Basic Shares Outstanding | 46.41% | 42.83% | 1.16% | -52.98% | |
| Average Diluted Shares Outstanding | 46.41% | 42.83% | 1.16% | -52.98% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |